16 results
Keyword Blinatumomab Remove keyword
Type of content
Others Remove Others filter
-
List item
National expert: Christina Peters, European Medicines Agency (updated)
- Declaration of interests - 82.64 KB | PDF
- Curriculum Vitae - 133.32 KB | PDF
02/2013-(current) Amgen Blinatumomab resistant CD19 positive acute … Indication 02/2013-(current) Amgen Blinatumomab resistant acute lymphoblastic leukaemia 2.6 … Indication 06/2014-(current) Amgen Blinatumomab Resistant paediatric acute … -
List item
National expert: Gonzalo Calvo Rojas, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 85.65 KB | PDF
- Curriculum Vitae - 72.19 KB | PDF
04/2015-04/2015 Amgen Blinatumomab ALL 04/2015-04/2015 Amgen … -
List item
Medicines under evaluation
Last updated: 18/02/2019 -
List item
PRAC: Agendas, minutes and highlights
Last updated: 14/06/2019 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 28/01/2019 -
List item
Recommendations on medication errors
Last updated: 31/01/2017Blincyto, INN-blinatumomab 30 Churchill Place … cancer medicine Blincyto (blinatumomab) is used in a safe and effective … contains the active substance blinatumomab. More information on Blincyto …
-
List item
COMP: Agendas, minutes and meeting reports
Last updated: 24/02/2016 -
List item
CHMP: meeting archive 2013-2015
-
List item
Annual reports and work programmes
Last updated: 03/05/2019 -
List item
PDCO: Agendas, minutes and meeting reports
Last updated: 17/08/2016 -
List item
COMP: meeting archive 2007-2011
-
List item
Newsletters
Last updated: 02/02/2017 -
List item
PRAC: meeting archive 2014-2015
-
List item
Newsletter archive
authorised Blincyto (blinatumomab) Treatment of Philadelphia … medication errors Blincyto (blinatumomab) - educational materials …
-
List item
COMP: meeting archive 2012-2014
-
List item
PDCO: meeting archive 2012-2014